Skip to content

Sebi may soften P-note blow

In a move that could be of some relief to foreign institutional investors (FIIs), the Securities and Exchange Board of India(Sebi) is considering a proposal to allow proprietary sub-accounts to issue participatory notes (P-notes).

Sebi Chairman M Damodaran is expected to discuss these and other proposals when he meets representatives of FIIs and hedge funds through a video conference on Monday.

Sebi is expected to finalise the guidelines at its board meeting on October 25.

Last week, the market regulator had proposed, among other things, a general ban on sub-accounts of FIIs issuing P-notes, which are offshore derivative instruments used by hedge funds and investors that are not registered in India.

Many FIIs, however, have proprietary sub-account that are formed to invest their own money. These sub-accounts issue P-notes purely as an investment opportunity to earn a good return at minimum cost.

Proprietary sub-accounts are different from other sub-accounts that are largely corporate structures or special purpose vehicles formed in tax havens by unregistered investors, with FIIs investing the money on their behalf.

FIIs are of the view that they are already registered so there should not be a ban on P-notes issued by their own sub-accounts.

Sebi had proposed various controls on P-notes last week as a means of controlling massive capital inflows.

The other proposal that is under Sebi's active consideration is to allow FIIs to hedge equity investments through P-notes that they issue.

While P- notes on equity instruments are allowed, Sebi had proposed to ban FIIs from issuing P-notes in derivatives, which makes hedging difficult.

The absence of a hedging facility for P-notes investments was one of the bigger concerns of foreign investors and played a major role in last week's steep stock market fall.

Meanwhile, sources said the government was also considering a turnover tax on issuance and trading volumes of P-Notes in the long term.

While FIIs pay capital gains tax on their transactions, there is no tax on P-notes since they do not originate in India. However, to discourage the issuance of P-notes, a turnover tax is being considered.

To simplify registration norms for FIIs – the lack of which was one of the key reasons for the massive growth of P-notes in recent months – Sebi proposes to approach the Reserve Bank of India to put clearance under the Foreign Exchange Management Act on the fast track.

According to Sebi, P-notes now account for more than half of the FII inflows from 34 per cent two years ago.

Source: Rediff

Posted in Main Page.

No Responses (yet)

Stay in touch with the conversation, subscribe to the RSS feed for comments on this post.

Some HTML is OK

or, reply to this post via trackback.

Disclaimer: The website solely provides information about HEDGE FUNDS INDIA space. No data or statement herein is or should be construed to be a recommendation for the purchase, retention, or sale of the securities referred to herein and we accept no liability for the consequences of your reliance on this data and information. The value of investments and the income derived from them may fall as well as rise. The information in this website is based on data gathered from publicly available websites and other information mediums. We have not independently verified such information , do not represent it as accurate, true or complete, make no warranty, express or implied regarding it and shall not be liable for any losses, damages, costs or expenses relating to its adequacy, accuracy, truth, completeness or use. Investments in hedge funds, private equity, venture capital and other private investment funds are speculative and involve a high degree of risk. You could lose all or a substantial amount of your investment. This website does not list, and does not purport to list, the risk factors associated with an investment in any of the funds listed on this site. We do not represent any hedge funds, private equity or investment/financial advisors nor give any investment recommendations.